Novo Nordisk
NVO
#103
Rank
S$210.71 B
Marketcap
S$47.11
Share price
0.98%
Change (1 day)
-51.32%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report